DrugId:  1
1. Name:  Beloranib
2. Groups:  Investigational
3. Description:  Beloranib has been used in trials studying the treatment of Obesity, Over-weight, Type 2 Diabetes, Craniopharyngioma, and Hypothalamic Injury, among others.
4. Indication:  Not Available
